Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, ...

Chronic migraineurs who started GLP-1 drugs also were 14% less likely to be hospitalized (RR 0.86, 95% CI 0.81-0.91), and ...

Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines.

As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.

NICE recommended rimegepant in 2023 for treating migraine and preventing episodic attacks (between 4 and 14 migraines per month), and atogepant in 2024 for preventing both episodic and chronic ...

A New Way Forward for Migraine Treatment The study involved 26 adults who also suffered from obesity and chronic migraine. For them, headaches were an all-too-common occurrence—more than 15 days a ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. A GLP-1 agonist, the same class of drugs as Ozempic, may treat migraine, a study finds. | Credit: ...

Emgality is a monthly subcutaneous injection used to prevent episodic and chronic migraine. Migraine is a condition that causes intense throbbing or pulsating on one side of the head. Migraine may ...

Triangle Business Journal will recognize the robust growth of the Life Sciences sector in the Triangle. Nominations will be ...

The third phase of a migraine attack is the headache. This is when people typically experience a throbbing or pulsating ...

A small trial found that taking the GPL-1 medication liraglutide reduced headache frequency in people with obesity. Fact checked by Nick Blackmer Popular diabetes and weight loss medications like ...

Migraine attacks can be painful to experience, and many medications are available to help with treatment. One systematic review and network meta-analysis found that certain triptans may be more ...